Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study

Preventive Medicine

Volumn 61, Issue , 2014, Pages 66-74

  Marrugat, Jaume ^a   Subirana, Isaac ^a,b   Ramos, Rafel ^c   Vila, Joan ^a,b   Marín Ibañez, Alejandro ^d   Guembe, María Jesús ^e,f   Rigo, Fernando ^g   Tormo Díaz, María José ^b,h   Moreno Iribas, Conchi ^b,e,i   Cabré, Joan Josep ^j   Segura, Antonio ^k   Baena Díez, José Miguel ^l   de la Cámara, Agustín Gómez ^b,m   Lapetra, José ^b,n   Grau, María ^a   Quesada, Miquel ^c   Medrano, María José ^o   González Diego, Paulino ^e   Frontera, Guiem ^g   Gavrila, Diana ^b,h   Aicua, Eva Ardanaz ^b,e,i   Basora, Josep ^b,j   García, José María ^k   García Lareo, Manuel ^l   Gutierrez, José Antonio ^h   Mayoral, Eduardo ^b,p   Sala, Joan ^q   D'Agostino, Ralph ^r   Elosua, Roberto ^a,b   more..

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Investigación en Atención Primaria Jordi Gol   (Spain)

^d Centro de Salud San Jose Norte   (Spain)

^e Grupo de Investigación Riesgo Vascular en Navarra RIVANA   (Spain)

^f Gobierno de Navarra   (Spain)

^g Grupo Cardiovascular de Baleares de la REDIAP IBSALUT   (Spain)

^h Edificio Centro   (Spain)

ⁱ INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^j INSTITUT CATALÀ DE LA SALUT   (Spain)

^k INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^l Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^m CIBEROBN FEDER ERDF Instituto de Salud Carlos III ^*  (Spain)

ⁿ Servicio Andaluz de Salud   (Spain)

^o CARLOS III INSTITUTE OF HEALTH   (Spain)

^p Sociedad Andaluza de Medicina Familiar Y Comunitara SAMFyC   (Spain)

^q HOSPITAL JOSEP TRUETA   (Spain)

^r FRAMINGHAM HEART STUDY   (United States)

more..

Author keywords

Cardiovascular diseases; Coronary disease; Prevention; Risk functions; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; EXAMINATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REGISTER; SEX RATIO; SMOKING; SPAIN; SYSTOLIC BLOOD PRESSURE; TELEPHONE; VALIDATION STUDY; BLOOD; CARDIOVASCULAR DISEASES; KAPLAN MEIER METHOD; MIDDLE AGED; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SURVIVAL; TRENDS;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MORTALITY; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 84893664571     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.12.031     Document Type: Article

References (38)

1. Alzamora M.T., Forés R., Baena-Díez J.M., et al. The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health 2010, 10:38.
2. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002, 105:310-315.
3. Cabré J.J., Martín F., Costa B., et al. Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. BMC Public Health 2008, 8:251.
4. D'Agostino R.B., Nam B.H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Survival Methods 2004, vol. 23:1-25. Elsevier BV, Amsterdam, (doi:10.16/S0169-7161(03)23001-7). N. Balakrishnan, C.R. Rao (Eds.).
5. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187. CHD Risk Prediction Group.
6. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
7. Development Core Team R. R: A Language and Environment for Statistical Computing 2011, R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org/.
8. Emberson J., Whincup P., Morris R., Walker M., Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur. Heart J. 2004, 25:484-491.
9. Gaziano T.A., Young C.R., Fitzmaurice G., Atwood S., Gaziano J.M. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort. Lancet 2008, 371:923-931.
10. Grau M., Subirana I., Elosua R., et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:653-659.
11. Grau M., Elosua R., Cabrera de León A., et al. Cardiovascular risk factors in Spain in the first decade of the 21st century: a meta-analysis with individual data from 11 population-based studies, DARIOS Study. Rev Esp Cardiol 2011, 64:295-304.
12. Guembe M.J. Prevalencia de factores de riesgo vascular en Navarra 1993. Bol. Salud. Public. Nav. 1994, 7:2-8.
13. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007, 335:136-148.
14. Huerta J.M., Tormo M.J., Gavrila D., Navarro C. Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors. BMC Public Health 2010, 10:640.
15. Kannel W.B., D'Agostino R.B., Sullivan L., Wilson P.W. Concept and usefulness of cardiovascular risk profiles. Am. Heart J. 2004, 148:16-26.
16. Lloyd-Jones D.M., Wilson P.W., Larson M.G., et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am. J. Cardiol. 2004, 94:20-24.
17. Mainous A.G., Koopman R.J., Diaz V.A., Everett C.J., Wilson P.W., Tilley B.C. A coronary heart disease risk score based on patient-reported information. Am. J. Cardiol. 2007, 99:1236-1241.
18. Marín A., Medrano M.J., González J., et al. Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting. BMC Public Health 2006, 6:38.
19. Marrugat J., Solanas P., D'Agostino R., et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev. Esp. Cardiol. 2003, 56:253-261.
20. Marrugat J., Subirana I., Comín E., et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J. Epidemiol. Community Health 2007, 61:40-47.
21. Marrugat J., Vila J., Baena-Díez J.M., et al. Validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR Study. Rev. Esp. Cardiol. 2011, 64:385-394.
22. Meyers D.G., Neuberger J.S., He J. Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol. 2009;54:1249-55. Erratum in. J. Am. Coll. Cardiol. 2009, 54:1902.
23. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Circulation 2002, 106:3143-3421.
24. Pencina M.J., D'Agostino R.B., Larson M.G., Massaro J.M., Vasan R.S. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation 2009, 119:3078-3084.
25. Pencina M.J., D'Agostino R.B., Demler O.V. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat. Med. 2012, 31:101-113.
26. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2012, 33:1635-1701.
27. Ramos R., Balló E., Marrugat J., et al. Validez del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) en el estudio de enfermedades vasculares: Estudio EMMA. Rev. Esp. Cardiol. 2012, 65:29-37.
28. Reiner Z., Catapano A.L., De Backer G., et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 2011, 32:1769-1818.
29. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 2007, 297:611-619. (Erratum in: JAMA. 2007;297:1433).
30. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 2008, 118:2243-2251.
31. Rigo Carratala F., Frontera Juan G., Llobera Cànaves J., Rodríguez Ruiz T., Borrás Bosch I., Vidal Fuentespina E. Prevalencia de factores de riesgo cardiovascular en las Islas Baleares (estudio CORSAIB). Rev. Esp. Cardiol. 2005, 58:1411-1419.
32. Rose G. Sick individuals and sick populations. Int. J. Epidemiol. 1985, 14:32-38.
33. Santos J.M., Urbano V., Mayoral E., et al. Prevalence of the metabolic syndrome in andalusian population according to the definitions of ATPIII and International Diabetes Federation. Obes. Metab. 2009, 5(Suppl. 1):38.
34. Segura Fragoso A., Rius Mery G. Factores de riesgo cardiovascular en una población rural de Castilla - La Mancha. Rev. Esp. Cardiol. 1999, 52:577-588.
35. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
36. Viñes J.J., Díez J., Guembe M.J., et al. Estudio de riesgo vascular en Navarra: objetivos y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular. An. Sist. Sanit. Navar. 2007, 30:113-124.
37. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
38. Wolf P.A., D'Agostino R.B., Belanger A.J., Kannel W.B. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991, 22:312-318.